29 results on '"Lavy-Shahaf G"'
Search Results
2. Tumor Treating Fields (TTFields) for Newly Diagnosed Glioblastoma in the Real World: A Systematic Review and Survival Meta-Analysis
3. LBA3 Tumor Treating Fields (TTFields) therapy plus XELOX chemotherapy for front line treatment of advanced unresectable gastroesophageal junction adenocarcinoma (GEJC) or gastric adenocarcinoma (GC): A multicenter phase II trial
4. Investigation of in vitro response to TTFields and related gene expression in 45 human cell lines
5. EF-14 Phase III post-hoc analysis - TTFields affect tumour growth rates
6. The Long Tail Problem: Novel Parametric Methods Still Underestimate Conditional Long-Term Survival In Glioblastoma
7. PCN287 RESPONDER-BASED PARAMETRIC MODELS UNDERESTIMATE LONG-TERM SURVIVAL IN GLIOBLASTOMA
8. Increased survival benefit for newly diagnosed glioblastoma patients with higher TTFields doses to the tumour bed
9. P11.20 Assessing TTFields-response and associated gene expression in various human cancer cell lines
10. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL
11. Correlation of TTFields Dose Density and Survival Outcomes in Newly Diagnosed Glioblastoma: A Numerical Simulation-Based Analysis of Patient Data from the EF-14 Randomized Trial.
12. P04.17 Cancer cell lines response to tumor treating fields: results of a meta-analysis
13. P04.57 Creating patient-specific computational head models for the study of tissue-electric field interactions using deformable templates
14. P01.065 Tumor treating fields (TTFields) in combination with lomustine (CCNU) in the EF-14 phase 3 clinical study - a safety analysis
15. P01.113 Increasing TTFields dose to the tumor bed improves overall survival in newly diagnosed glioblastoma patients
16. PANOVA-3: A phase 3 study of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma - Trial in progress
17. Tumor Treating Fields (TTFields)—A Novel Cancer Treatment Modality: Translating Preclinical Evidence and Engineering Into a Survival Benefit with Delayed Decline in Quality of Life
18. P-185 - PANOVA-3: A phase 3 study of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine for front-line treatment of locally-advanced pancreatic adenocarcinoma - Trial in progress
19. 334PD - Tumor Treating Fields (TTFields) – A novel cancer treatment modality: Translating preclinical evidence and engineering into a survival benefit with delayed decline in quality of life
20. P01.057 Effects of tumor treating fields on health-related quality of life (HRQoL) in newly diagnosed glioblastoma: An exploratory analysis of the EF-14 randomized phase III trial.
21. Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro , and safety for application to COVID-19 patients in a pilot clinical study.
22. Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis.
23. The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.
24. MiR-21, EGFR and PTEN in non-small cell lung cancer: an in situ hybridisation and immunohistochemistry study.
25. Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial.
26. Investigating the Connection Between Tumor-Treating Fields Distribution in the Brain and Glioblastoma Patient Outcomes. A Simulation-Based Study Utilizing a Novel Model Creation Technique
27. Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.
28. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
29. Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.